MCRB stock

Seres Therapeutics Inc (MCRB) financials · rev $789.0K

Lician Pro · $19.99/mo or $149/yrCompare AAPL vs MSFT

Seres Therapeutics Inc (MCRB) rev $789.0K.

Cached annual income statement
LineFY2025FY2024
Revenue$789.0KN/A
Operating Income-$94.0M-$121.3M
Net Income$5.70M$136.0K
EPS (Diluted)$0.64N/A
Cached annual balance sheet
LineFY2025FY2024
Total Assets$138.2M$139.8M
Current Assets$49.4M$38.7M
Cash & Equivalents$45.8M$30.8M
PP&E$7.63M$11.5M
Total Liabilities$94.0M$126.0M
Current Liabilities$19.3M$41.2M
Shareholders' Equity$44.2M$13.8M
Retained Earnings-$972.4M-$978.1M
Cached annual cash flow
LineFY2025FY2024
Operating Cash Flow$1.12M-$148.6M
CapEx$252.0K$380.0K
Investing Cash Flow-$42.0K$142.3M
Financing Cash Flow$13.9M-$90.4M
Free Cash Flow$865.0K-$149.0M
These statements as JSON? API free 100/day

FAQ

What is MCRB P/E and revenue?

Seres Therapeutics Inc (MCRB) rev $789.0K.

What is MCRB revenue?

Seres Therapeutics Inc last cached revenue is $789.0K (FY2025).

Is MCRB profitable?

Seres Therapeutics Inc last cached net income is $5.70M (FY2025).

What are MCRB total assets?

Seres Therapeutics Inc last cached total assets are $138.2M (FY2025).

What is MCRB free cash flow?

Seres Therapeutics Inc last cached free cash flow is $865.0K (FY2025).

Not investment advice. Cached statements, not a live tape.